OverviewSuggest Edit

Bausch Health Companies (formerly known as Valeant Pharmaceuticals) is a multinational specialty pharmaceutical and medical device company. It develops, manufactures and markets a broad range of prescription and non-prescription pharmaceutical products. The Company's primary focus is in the areas of dermatology and eye health. In addition, the Company provides branded generic products in antibiotics, antifungal medications, diabetic therapies, antibacterials and vitamin deficiency.

TypePublic
Founded1960
HQLaval, CA
Websitebauschhealth.com
Employee Ratings2.8

Latest Updates

Employees (est.) (Dec 2019)21,700(+3%)
Revenue (FY, 2019)$8.6 B(+3%)
Share Price (Jul 2020)C$24.5 (-7%)
Cybersecurity ratingBMore

Key People/Management at Bausch Health Companies

Joseph C. Papa

Joseph C. Papa

Chairman of the Board and Chief Executive Officer
Thomas J. Appio

Thomas J. Appio

President & Co-Head, Bausch + Lomb/International
Christina M. Ackermann

Christina M. Ackermann

Executive Vice President, General Counsel, Head of Commercial Operations
Paul S. Herendeen

Paul S. Herendeen

Executive Vice President and Chief Financial Officer
Dennis Asharin

Dennis Asharin

Senior Vice President, Chief Global Manufacturing and Supply Chain Officer
Joseph Gordon

Joseph Gordon

President & Co-Head, BauschLomb/International
Show more

Bausch Health Companies Office Locations

Bausch Health Companies has offices in Laval, Steinbach, Bridgewater Township, Clearwater and in 30 other locations
Laval, CA (HQ)
2150 St. Elzéar Blvd. West
Steinbach, CA
100 Life Sciences Pkwy
Sarajevo, BA
Fra Anđela Zvizdovića 1
Sofia, BG
Krasno selo
Tallinn, EE
A. H. Tammsaare tee 47
München, DE
Messerschmittstraße 1+3
Show all (41)

Bausch Health Companies Financials and Metrics

Bausch Health Companies Revenue

Bausch Health Companies's revenue was reported to be $8.60 b in FY, 2019
USD

Revenue (Q2, 2020)

1.6b

Gross profit (Q2, 2020)

1.2b

Gross profit margin (Q2, 2020), %

70.6%

Market capitalization (27-Apr-2020)

8.9b

Closing stock price (27-Apr-2020)

25.4

Cash (30-Jun-2020)

896.0m

EV

32.4b
Bausch Health Companies's current market capitalization is C$8.9 b.
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

1.2b2.5b3.5b5.8b8.3b10.4b9.7b8.7b8.4b8.6b

Revenue growth, %

43%26%(7%)(10%)

Cost of goods sold

395.6m683.8m921.5m1.8b2.5b

Gross profit

785.6m1.8b2.6b3.9b6.2b
Quarterly
USDQ2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

238.8m208.3m565.0m609.4m600.6m856.1m820.1m884.1m1.1b1.1b1.5b1.9b2.8b2.1b2.2b2.2b2.0b4.1b2.1b2.0b2.2b2.2b2.0b1.6b

Cost of goods sold

63.9m62.1m169.3m169.9m162.6m238.8m197.3m219.7m284.9m283.2m560.9m504.1m634.6m584.0m635.0m650.0m560.0m1.1b482.0m

Gross profit

174.9m146.1m395.7m439.5m438.0m617.3m622.8m664.5m783.5m812.6m980.9m1.4b2.2b1.5b1.6b1.6b1.4b3.0b1.2b

Gross profit Margin, %

73%70%70%72%73%72%76%75%73%74%64%73%77%72%72%71%72%72%71%
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

394.3m164.1m916.1m600.3m322.6m597.3m542.0m720.0m721.0m3.2b

Accounts Receivable

274.8m468.5m769.5m1.8b2.1b2.7b2.5b2.1b1.9b1.8b

Prepaid Expenses

26.1m33.7m125.9m771.0m689.0m779.0m

Inventories

229.6m355.2m531.3m205.0m641.9m966.4m1.1b1.0b934.0m1.1b
Quarterly
USDQ2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

176.6m592.7m401.8m238.9m254.6m330.5m395.3m257.7m413.7m2.5b596.3m576.3m531.2m808.8m1.9b958.0m1.4b1.3b852.4m658.5m1.2b1.2b964.0m909.0m838.0m973.0m782.0m878.0m825.0m912.0m896.0m

Accounts Receivable

114.4m291.1m471.1m411.5m450.4m613.6m611.2m805.0m1.1b1.1b1.6b1.7b1.8b1.9b2.1b2.4b2.7b2.7b2.7b2.7b2.1b2.1b2.2b1.9b2.0b2.0b1.8b1.8b1.7b1.7b1.4b

Prepaid Expenses

9.6m41.2m33.8m25.0m32.9m52.5m56.5m72.2m136.7m115.5m736.0m757.0m693.0m698.0m631.0m745.0m776.0m

Inventories

88.1m295.3m266.1m259.8m259.6m373.5m388.7m418.3m509.7m497.1m1.1b953.4m942.5m932.7m998.9m1.2b1.2b1.3b1.3b1.3b1.1b1.1b1.1b1.0b993.0m971.0m1.0b1.1b1.1b1.1b1.2b
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(208.2m)720.7m882.3m(863.7m)912.2m(287.8m)(2.4b)2.4b(4.1b)(1.8b)

Depreciation and Amortization

612.6m986.2m2.9b2.8b2.1b

Inventories

7.5m(11.5m)(80.3m)(120.0m)(170.0m)(280.0m)(164.0m)7.0m(5.0m)(209.0m)

Accounts Payable

(76.1m)(9.0m)(29.1m)387.0m(121.0m)(149.0m)
Quarterly
USDQ2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

30.8m(177.1m)6.5m62.8m103.7m(12.9m)410.4m671.5m213.8m479.3m(972.0m)(20.3m)122.0m276.4m74.5m(51.6m)51.7m(372.9m)(676.9m)(1.9b)629.0m592.0m1.9b(2.7b)(3.5b)(3.8b)(48.0m)(218.0m)(266.0m)(152.0m)(477.0m)

Depreciation and Amortization

231.6m371.9m215.6m437.4m672.8m341.4m659.3m635.0m2.0b2.3b532.0m1.1b1.6b481.0m961.0m

Inventories

(5.8m)(4.1m)13.4m5.1m(68.0k)(35.1m)(51.5m)(61.3m)(24.9m)(58.9m)(46.1m)(69.2m)(12.1m)(41.5m)(38.5m)(48.3m)(45.6m)(85.9m)(145.1m)(166.3m)(38.0m)1.0m(12.0m)(8.0m)(68.0m)(121.0m)(205.0m)(94.0m)(188.0m)

Accounts Payable

(30.3m)(8.0m)(37.8m)(10.3m)6.5m(9.9m)(26.2m)58.2m9.2m56.6m299.0m107.0m(4.0m)(59.0m)(33.0m)(85.0m)(356.0m)
USDQ2, 2010

Financial Leverage

1.5 x
Show all financial metrics

Bausch Health Companies Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

SecurityScorecard logo

Bausch Health Companies Revenue Breakdown

Embed Graph

Bausch Health Companies revenue breakdown by business segment: 15.8% from U.S. Diversified Products, 55.8% from Bausch + Lomb/International and 28.4% from Branded Rx

Bausch Health Companies revenue breakdown by geographic segment: 59.9% from U.S. and Puerto Rico and 40.1% from Other

Bausch Health Companies Online and Social Media Presence

Embed Graph

Bausch Health Companies News and Updates

Bausch Health Companies Inc. Announces Second-Quarter 2020 Results

LAVAL, QC, Aug. 6, 2020 /PRNewswire/ -- Second-Quarter 2020 Financial Results Revenues of $1.664 Billion; Meaningfully Impacted by the COVID-19 Pandemic GAAP Net Loss of $326 Million Adjusted EBITDA (non-GAAP)1 of $622 Million GAAP Cash Generated from Operations of $200 Million Narrowed...

Global Contact Lens Market Study 2020-2025 Featuring Profiles of Major Players Essilor Int'l, Novartis, Bausch Health Companies, Zeiss Group, and the Cooper Companies Amongst Others

DUBLIN, July 6, 2020 /PRNewswire/ -- The "Contact Lens Market- Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The global contact lens market is projected to register a CAGR of 5.92% during the forecast period, 2020 to 2025. In order...

After 35% Decline Does Bausch Health Companies Stock Look Attractive?

Bausch Health Companies, best known for its contact lenses and branded generic drugs, has seen its stock fall more than 35% year-to-date, as the coronavirus pandemic is expected to have a meaningful impact on its businesses. BHC stock also remains down by about 11% from levels seen in early 2018...

Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2019 Results And Provides 2020 Guidance

LAVAL, Quebec, Feb. 19, 2020 /PRNewswire/ -- Fourth-Quarter 2019 Financial Results Revenues of $2.224 Billion GAAP Cash Generated from Operations of $234 Million GAAP Net Loss of $1.516 Billion Adjusted EBITDA (non-GAAP)1 of $898 Million Full-Year 2019 Financial Results Revenues of $8.601...

Medical Aesthetics Market is Growing at a CAGR of 12% During Forecasted Period 2019 to 2026| Key Companies Mentioned in the Report are Allergan, Bausch Health Companies, Cutera, Eclipse, Lutronic, Mentor Worldwide

SAN FRANCISCO, Oct. 17, 2019 /PRNewswire/ -- According to Data Bridge Market Research, Global Medical Aesthetics Market is expected to be growing at a healthy CAGR of 12.1% during the forecast period of 2019 to 2026. The latest market evaluation report on Global Medical Aesthetics Market...

Bausch Health Companies Inc. Will Release Third-Quarter 2019 Financial Results on November 4

LAVAL, Quebec, Oct. 4, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its third-quarter 2019 financial results on Monday, Nov. 4, 2019. Bausch Health will host a conference call and live web cast at 8:00 a.m. EST to discuss the results and...
Show more

Bausch Health Companies Frequently Asked Questions

  • When was Bausch Health Companies founded?

    Bausch Health Companies was founded in 1960.

  • Who are Bausch Health Companies key executives?

    Bausch Health Companies's key executives are Joseph C. Papa, Thomas J. Appio and Christina M. Ackermann.

  • How many employees does Bausch Health Companies have?

    Bausch Health Companies has 21,700 employees.

  • What is Bausch Health Companies revenue?

    Latest Bausch Health Companies annual revenue is $8.6 b.

  • What is Bausch Health Companies revenue per employee?

    Latest Bausch Health Companies revenue per employee is $396.4 k.

  • Who are Bausch Health Companies competitors?

    Competitors of Bausch Health Companies include Pfizer, Merck and Novartis.

  • Where is Bausch Health Companies headquarters?

    Bausch Health Companies headquarters is located at 2150 St. Elzéar Blvd. West, Laval.

  • Where are Bausch Health Companies offices?

    Bausch Health Companies has offices in Laval, Steinbach, Bridgewater Township, Clearwater and in 30 other locations.

  • How many offices does Bausch Health Companies have?

    Bausch Health Companies has 41 offices.